ALAIN SCHREIBER

CIK 1225149 · last filed 2017-04-27

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$31.46M

Companies

5

Total Filings

26

Lifetime Open-Market Net

-$4.20M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Director 18,477 $2.14 $39.5K -$18.94M 5 2017-04-27
AGILE THERAPEUTICS INC (AGRX) Delisted 10%+ Owner 4,668,663 $1.51 $7.05M $28.50M 1 2015-01-23
AVANIR PHARMACEUTICALS, INC. (AVNR) Delisted 10%+ Owner 8,100,034 -$13.84M 4 2009-10-13
NVD 10%+ Owner 6,267,570 $5.02 $31.46M $2.79M 3 2008-12-23
CADENCE PHARMACEUTICALS INC (CADX) Delisted Director 3,013,269 -$2.70M 3 2007-09-04

Recent Filings · Page 3 of 3

26 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-09-04 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −172,200 -$2.49M EDGAR
2007-08-31 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −12,900 -$181.9K EDGAR
2007-08-24 CADENCE PHARMACEUTICALS INC (CADX) Delisted Sell (S) −1,800 -$26.1K EDGAR
2007-04-03 Conv (C) +150,000 $1.05M
2007-02-14 Mixed +1,179,463 $110.8K
2007-01-26 NVD Buy (P) +1,923,828 $2.79M EDGAR
Showing 2126 of 26
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.